[Des-Arg9]-Bradykinin acetate (Synonyms: [Des-Arg9]-缓激肽醋酸盐) 纯度: 96.90%
[Des-Arg9]-Bradykinin acetate 是缓激肽 B1 受体 (Bradykinin B1 receptor) 激动剂,对 B1 受体的选择性高于 B2 受体。
[Des-Arg9]-Bradykinin acetate Chemical Structure
CAS No. : 23827-91-0
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
5 mg | ¥550 | In-stock | |
10 mg | ¥880 | In-stock | |
25 mg | ¥1900 | In-stock | |
50 mg | 询价 | ||
100 mg | 询价 |
* Please select Quantity before adding items.
[Des-Arg9]-Bradykinin acetate 相关产品
•相关化合物库:
- Bioactive Compound Library Plus
- Peptidomimetic Library
- Peptide Library
生物活性 |
[Des-Arg9]-Bradykinin acetate is a Bradykinin B1 receptor agonist that displays selectivity for B1 over B2 receptors. |
IC50 & Target |
Bradykinin B1 receptor[1] |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
体外研究 (In Vitro) |
[Des-Arg9]-Bradykinin acetate is a Bradykinin(B1) receptor agonist. The B2 receptor mediates the action of bradykinin (BK) and lysyl-bradykinin (Lys-BK), the first set of bioactive kinins formed in response to injury from kininogen precursors through the actions of plasma and tissue kallikreins, whereas the B1 receptor mediates the action of [Des-Arg9]-Bradykinin (des-Arg9-BK) and Lys-des-Arg Arg9-BK, the second set of bioactive kinins formed through the actions of carboxypeptidases on BK and Lys-BK, respectively[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
分子量 |
964.07 |
||||||||||||||||
Formula |
C46H65N11O12 |
||||||||||||||||
CAS 号 |
23827-91-0 |
||||||||||||||||
Sequence |
Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe |
||||||||||||||||
Sequence Shortening |
RPPGFSPF |
||||||||||||||||
中文名称 |
[Des-Arg9]-缓激肽醋酸盐 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
||||||||||||||||
溶解性数据 |
In Vitro:
H2O : 100 mg/mL (103.73 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
||||||||||||||||
参考文献 |
|
-
[1]. Leeb-Lundberg LM, et al. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev. 2005 Mar;57(1):27-77.